Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proter is an Italian pharmaceutical company with a long-standing history in the development and manufacturing of essential medicines, particularly antibiotics and respiratory treatments. Founded in 1948, the company became a significant player in the Italian market, known for its production of amoxicillin and other anti-infective agents. While its primary manufacturing operations were historically integrated into larger pharmaceutical groups like Sanofi-Aventis, the Proter brand continues to operate in the specialty pharma space. Today, the company focuses on commercializing a portfolio of products in therapeutic areas such as respiratory health, osteoarticular diseases, and infectious diseases. Proter remains a recognized name in the Italian healthcare sector for its reliable supply of generic and specialty small molecule therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proter.